- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr David Blumenthal: Managed Care Needed for High-Need, High-Cost Patients
David Blumenthal, MD, MPP, president of The Commonwealth Fund, believes that managed care has lost some of its focus and he would like to see more attention paid to holistic management of care for the frailest, sickest patients.
David Blumenthal, MD, MPP, president of The Commonwealth Fund, believes that managed care has lost some of its focus and he would like to see more attention paid to holistic management of care for the frailest, sickest patients.
Transcript (slightly modified for readability)
What do you expect to see change in managed care in the next 20 years?
The definition of managed care is changing, and what we thought of as managed care, when managed care became a popular term about 20-25 years ago, has a little bit lost its focus. Many, many things have come under the rubric of managed care. For me, managed care means exactly what the term says: it means care that's carefully orchestrated, carefully coordinated, carefully fine-tuned for individuals.
And I think that as we look forward over the next 20 years, given demographic patterns, I hope we'll see much more attention to the holistic management of care for the frailest, sickest, most compromised patients and citizens in our country. I think the management of care for, what we call at The Commonwealth Fund, "high-need, high-cost patients" should be a theme that over the next 20 years gets increasing attention and at which we become really, really expert.
Implicitly, I'm saying that managed care is not maybe a unitary intervention, it's a tailored strategy in which intensive attention is given to how to adapt care to the needs of particular populations.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
High-Impact Trials at ACC.25 Signal Shift in Chronic Disease Treatment
April 4th 2025Experts highlight groundbreaking research presented at the American College of Cardiology Annual Scientific Session (ACC.25), which emphasized a shift toward more personalized, evidence-based treatment strategies.
Read More
Bridging Education Gaps in Treatment for Scarring Alopecia With Innovative Approaches
March 28th 2025Crystal Aguh, MD, FAAD, Johns Hopkins School of Medicine faculty, highlights the critical need for comprehensive education on hair loss across diverse hair types, stressing the importance of understanding inflammatory pathways for developing targeted therapies.
Read More
